| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1946 | 2020 |
| Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo, MS Lawrence, D Auclair, ... Cancer cell 25 (1), 91-101, 2014 | 1145 | 2014 |
| TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ... New England Journal of Medicine 375 (21), 2023-2036, 2016 | 880 | 2016 |
| Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma—a feasibility study VL Reichardt, CY Okada, A Liso, CJ Benike, KE Stockerl-Goldstein, ... Blood, The Journal of the American Society of Hematology 93 (7), 2411-2419, 1999 | 537 | 1999 |
| A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma AJ Jakubowiak, D Dytfeld, KA Griffith, D Lebovic, DH Vesole, S Jagannath, ... Blood, The Journal of the American Society of Hematology 120 (9), 1801-1809, 2012 | 528 | 2012 |
| Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma DG Maloney, AJ Molina, F Sahebi, KE Stockerl-Goldstein, BM Sandmaier, ... Blood 102 (9), 3447-3454, 2003 | 497 | 2003 |
| Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation I Pusic, SY Jiang, S Landua, GL Uy, MP Rettig, AF Cashen, P Westervelt, ... Biology of Blood and Marrow Transplantation 14 (9), 1045-1056, 2008 | 444 | 2008 |
| A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia GL Uy, MP Rettig, IH Motabi, K McFarland, KM Trinkaus, LM Hladnik, ... Blood, The Journal of the American Society of Hematology 119 (17), 3917-3924, 2012 | 442 | 2012 |
| Protective conditioning for acute graft-versus-host disease R Lowsky, T Takahashi, YP Liu, S Dejbakhsh-Jones, FC Grumet, ... New England Journal of Medicine 353 (13), 1321-1331, 2005 | 384 | 2005 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 320 | 2021 |
| Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma SM Horwitz, RS Negrin, KG Blume, S Breslin, MJ Stuart, ... Blood 103 (3), 777-783, 2004 | 266 | 2004 |
| Multiple myeloma, version 3.2017, NCCN clinical practice guidelines in oncology SK Kumar, NS Callander, M Alsina, D Atanackovic, JS Biermann, ... Journal of the National Comprehensive Cancer Network 15 (2), 230-269, 2017 | 236 | 2017 |
| Transplantation of highly purified CD34+ Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer RS Negrin, K Atkinson, T Leemhuis, E Hanania, C Juttner, K Tierney, ... Biology of Blood and Marrow Transplantation 6 (3), 262-271, 2000 | 223 | 2000 |
| Multiple myeloma, version 3.2021, NCCN clinical practice guidelines in oncology SK Kumar, NS Callander, K Adekola, L Anderson, M Baljevic, ... Journal of the National Comprehensive Cancer Network 18 (12), 1685-1717, 2020 | 216 | 2020 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 189 | 2021 |
| Effect of oral glutamine supplementation during bone marrow transplantation TM Coghlin Dickson, RM Wong, RS Negrin, JA Shizuru, LJ Johnston, ... Journal of Parenteral and Enteral Nutrition 24 (2), 61-66, 2000 | 186 | 2000 |
| Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients S Auffermann-Gretzinger, IS Lossos, TA Vayntrub, W Leong, FC Grumet, ... Blood, The Journal of the American Society of Hematology 99 (4), 1442-1448, 2002 | 181 | 2002 |
| Maintenance therapy with decitabine after allogeneic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome I Pusic, J Choi, MA Fiala, F Gao, M Holt, AF Cashen, R Vij, CN Abboud, ... Biology of Blood and Marrow Transplantation 21 (10), 1761-1769, 2015 | 176 | 2015 |
| Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma A Liso, KE Stockerl-Goldstein, S Auffermann-Gretzinger, CJ Benike, ... Biology of Blood and Marrow Transplantation 6 (6), 621-627, 2000 | 175 | 2000 |
| NCCN guidelines insights: Multiple myeloma, version 1.2020: Featured updates to the NCCN guidelines SK Kumar, NS Callander, J Hillengass, M Liedtke, M Baljevic, ... Journal of the National Comprehensive Cancer Network 17 (10), 1154-1165, 2019 | 164 | 2019 |
